MARC details
000 -LEADER |
fixed length control field |
04571cam a2200505Ii 4500 |
001 - CONTROL NUMBER |
control field |
on1044987027 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221128213458.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr cnu|||unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180721t20172017ne a obf 001 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
YDX |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9789062998838 |
Qualifying information |
(electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9062998836 |
Qualifying information |
(electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9789062992515 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
906299251X |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
1848428 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1044987027 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
085000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal author |
Roberts, Harry W., |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Current clinical evidence in ophthalmology |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Amsterdam, The Netherlands : |
Name of producer, publisher, distributor, manufacturer |
Kugler Publications, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2017] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
Includes index. |
505 0# - CONTENTS |
Contents |
Intro; Introduction; Preface; About the authors; List of Abbreviations; Anterior Segment; Herpetic Eye Disease Study -- 1 (HEDS -- 1); Herpetic Eye Disease Study -- 2 (HEDS -- 2); Endophthalmitis Vitrectomy Study (EVS); European Society for Cataract and RefractiveSurgeons (ESCRS Study); Collaborative Longitudinal Evaluation ofKeratoconus (CLEK); Corneal collagen cross-linking in progressivekeratoconus; Glaucoma; Ocular Hypertension Treatment Study (OHTS); European Glaucoma Prevention Study (EGPS); Early Manifest Glaucoma Trial (EMGT); United Kingdom Glaucoma Treatment Study(UKGTS). |
505 8# - CONTENTS |
Contents |
Advanced Glaucoma Intervention Study (AGIS)Collaborative Initial Glaucoma Treatment Study (CIGTS); Collaborative Normal-Tension Glaucoma Study(CNTGS); Low-Tension Glaucoma Treatment Study (LoGTS); Glaucoma Laser Trial (GLT); 5-Fluorouracil Filtering Surgery Study (FFSS); Tube Versus Trabeculectomy (TVT) study; Ahmed Baerveldt Comparison (ABC) and AhmedVersus Baerveldt (AVB) Studies; Effectiveness in Angle-closure Glaucoma of LensExtraction (EAGLE) Study; Retina; Diabetic Control and Complication Trial (DCCT)and Epidemiology of Diabetes Interventions andComplications (EDIC) trial. |
505 8# - CONTENTS |
Contents |
United Kingdom Prospective Diabetes Study (UKPDS)Diabetic Retinopathy Study (DRS); Early Treatment of Diabetic Retinopathy Study (ETDRS); DRCR.NET Protocol I -- Macular Laser Combinedwith Ranibizumab or Triamcinalone vs. MacularLaser Alone; DRCR.NET Protocol T -- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema; DRCR.NET Protocol S -- PanretinalPhotocoagulation vs. Intravitreal Ranibizumab forProliferative Diabetic Retinopathy; Fenofibrate Intervention and Event Lowering inDiabetes (FIELD); Diabetic Retinopathy Vitrectomy Study (DRVS). |
505 8# - CONTENTS |
Contents |
Ranibizumab for Diabetic Macular Oedema (RISE & RIDE)Ranibizumab Monotherapy or Combined with Laserversus Laser Monotherapy for Diabetic MacularEdema (RESTORE); Intravitreal Aflibercept for Diabetic Macular Edema(DA VINCI); Intravitreal Aflibercept for Diabetic Macular Edema (VIVID & VISTA); Bevacizumab or Laser Therapy in the Managementof Diabetic Macular Edema (BOLT); Fluocinolone Acetonide Vitreous Inserts forDiabetic Macular Edema (FAME A & B); The Age-Related Eye Disease Study (AREDS I). |
505 8# - CONTENTS |
Contents |
Lutein, Zeaxanthin and Omega-3 Fatty Acids forAge-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS-2)Ranibizumab vs. Verteporfin for PredominantlyClassic Choroidal Neovascularisation in Age-Related Macular Degeneration (ANCHOR); Ranibizumab for Minimally Classic or OccultNeovascular Age-Related Macular Degeneration (MARINA); Randomised, Double-Masked, Sham-ControlledTrial of Ranibizumab for Neovascular Age-relatedMacular Degeneration (PIER); Safety and Efficacy of a Flexible Dosing Regimen ofRanibizumab in Neovascular Age-Related MacularDegeneration (SUSTAIN). |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 072, 082 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Ophthalmology |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Gale, Jesse, |
Relator term |
author. |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Martin, Keith R., |
Relator term |
author. |
856 40 - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1848428">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1848428</a> |
Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 0# - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Online resource; title from PDF title page (EBSCO, January 11, 2019). |
938 ## - |
-- |
EBL - Ebook Library |
-- |
EBLB |
-- |
EBL5450696 |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
15597882 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
1848428 |
994 ## - |
-- |
92 |
-- |
N$T |